Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.56 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18668887 | 0.95 | SMN1; SMN2 (0.57) | SMN1; SMN2NPC1MAPTRAB9ACA1 | |
| SCHEMBL27824110 | 0.91 | SMN1; SMN2 (0.64) | SMN1; SMN2NPC1MAPTRAB9ACA1 | |
| SCHEMBL13291884 | 0.91 | SMN1; SMN2 (0.54) | SMN1; SMN2NPC1MAPTRAB9ACA1 | |
| SCHEMBL13256587 | 0.89 | SMN1; SMN2 (0.62) | SMN1; SMN2NPC1MAPTRAB9ACA1 | |
| SCHEMBL20073067 | 0.89 | MAPT (0.62) | SMN1; SMN2NPC1MAPTRAB9ACA1 | |
| SCHEMBL516998 | 0.88 | LMNA (0.72) | SMN1; SMN2NPC1MAPTRAB9ACA1 | |
| SCHEMBL11985689 | 0.87 | MAPT (0.73) | SMN1; SMN2NPC1MAPTRAB9ACA1 | |
| SCHEMBL726435 | 0.87 | TDP1 (0.63) | SMN1; SMN2NPC1MAPTRAB9ALMNA | |
| SCHEMBL12532606 | 0.86 | SMN1; SMN2 (0.59) | SMN1; SMN2NPC1MAPTRAB9ACA1 | |
| SCHEMBL1531975 | 0.86 | ALDH1A1 (0.56) | SMN1; SMN2MAPTRAB9ALMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743053-A1 | ANTIMICROBIAL SYNERGIES | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4554551-B1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | SYMRISE AG (DE) | 2026-03-11 | — | — | EP | claimed |
| EP-4554551-A1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | Symrise AG (DE) | 2025-05-21 | — | — | EP | claimed |
| WO-2025011739-A1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | SYMRISE AG (DE) | 2025-01-16 | — | — | WO | claimed |
| WO-2025012262-A1 | ANTIMICROBIAL SYNERGIES | SYMRISE AG (DE) | 2025-01-16 | — | — | WO | claimed |
| WO-2025011743-A1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL ACTIVES | SYMRISE AG (DE) | 2025-01-16 | — | — | WO | claimed |
| WO-2025012263-A1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | SYMRISE AG (DE) | 2025-01-16 | — | — | WO | claimed |
| CN-117320685-A | Composition for skin protection comprising an antimicrobial agent and a (bio) -alkanediol | 西姆莱斯股份公司 | 2023-12-29 | — | — | CN | claimed |
| US-20230293404-A1 | Compositions Comprising Natural Polymers and One or More (Bio)-Alkanediols | SYMRISE AG (DE) | 2023-09-21 | — | — | US | claimed |
| US-20230293409-A1 | Compositions Comprising Antimicrobials and (Bio)-Alkanediols for Skin Protection | SYMRISE AG (DE) | 2023-09-21 | — | — | US | claimed |
| CN-116615172-A | Composition comprising a natural polymer and one or more (bio) alkanediols | 西姆莱斯股份公司 | 2023-08-18 | — | — | CN | claimed |
| EP-4110476-A1 | COMPOSITIONS COMPRISING ANTIMICROBIALS AND (BIO)-ALKANEDIOLS FOR SKIN PROTECTION | Symrise AG (DE) | 2023-01-04 | — | — | EP | claimed |
| EP-4103143-A1 | COMPOSITIONS COMPRISING NATURAL POLYMERS AND ONE OR MORE (BIO)-ALKANEDIOLS | Symrise AG (DE) | 2022-12-21 | — | — | EP | claimed |
| WO-2022122898-A1 | COMPOSITIONS COMPRISING ANTIMICROBIALS AND (BIO)-ALKANEDIOLS FOR SKIN PROTECTION | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
| WO-2022122890-A1 | COMPOSITIONS COMPRISING NATURAL POLYMERS AND ONE OR MORE (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
| CN-109475120-B | Antimicrobial compositions | 西姆莱斯股份公司 | 2022-03-29 | — | — | CN | claimed |
| EP-4743053-A1 | ANTIMICROBIAL SYNERGIES | Symrise AG (DE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4554551-B1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | SYMRISE AG (DE) | 2026-03-11 | — | — | EP | disclosed |
| WO-2019072375-A1 | COMPOSITIONS CONTAINING BENZOIC ACID OR FUROIC ACID DERIVATIVES AND USE OF THE DERIVATIVES FOR EMULSION AND FOAM STABILITY | SYMRISE AG (DE) | 2019-04-18 | — | — | WO | disclosed |
| WO-2018068825-A1 | ANTIMICROBIAL COMPOSITIONS | SYMRISE AG (DE) | 2018-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293404-A1 | Compositions Comprising Natural Polymers and One or More (Bio)-Alkanediols | ACMSD, CUTA, DDC | SMN1; SMN2 2808/4885NPC1 3888/4885MAPT 662/4885 |
| US-20230293409-A1 | Compositions Comprising Antimicrobials and (Bio)-Alkanediols for Skin Protection | POLR1C, EBP, PIK3C3 | SMN1; SMN2 3596/4885NPC1 2186/4885MAPT 2601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.